Moreover, strategies that inhibited CD147 expression via lentivirus carrying CD147 shRNA or cDNA showed potential therapeutic effectiveness for lethal metastatic breast cancer through eliminating activated cancer stem cells (CSCs) (18). This evidence concerns the gene BSG and breast carcinoma.